InvestorsHub Logo
Followers 482
Posts 30219
Boards Moderated 0
Alias Born 06/15/2007

Re: None

Saturday, 09/23/2017 4:51:41 PM

Saturday, September 23, 2017 4:51:41 PM

Post# of 27676
I was aware of the following but I wanted to find out from RCHA as to the accuracy of it before posting. I just got an email back from $RCHA (inquiring about the information below) so am posting it now since obviously they are aware (which is obvious and made no sense otherwise). This was posted (it seems like it was) previously but I can't seem to locate the post.


We are all waiting on news. Hoping to see some significant NEWS come out soon IMHO.


HypGen uses Rich's phorbol esters IP in PD indication
Aug 2017



Executive Summary

HypGen Inc. (formerly Mega Bridge Inc.) will use Rich Pharmaceuticals Inc.'s intellectual property related to 12-O-tetradecanoylphorbol-13-acetate (TPA) to develop Parkinson's disease (PD) therapeutics.


https://scrip.pharmamedtechbi.com/deals/201720373


I hope everyone is having a great and safe weekend.



$RCHA



PEPSI



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.